Viewing nowCombinationEmpagliflozin/Metformin Film-Coated Tablets 12.5/850 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Donghwa Pharmaceutical Co., Ltd.

MFDS item code 202302633 · Approved 2023.09.05 · Insurance code 642707480
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood sugar control in adult patients with type 2 diabetes when combined with dietary and exercise regimens. Specifically, this medication helps manage blood sugar effectively with the combination of empagliflozin and metformin. Moreover, patients with type 2 diabetes and cardiovascular disease should check for precautions regarding the risk of cardiovascular events. Taking these aspects into account, the therapy should be tailored to the patient's health status, assisting in managing blood sugar and cardiovascular health together.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is used for treating diabetes and should not be administered to patients with poor kidney function or those experiencing acute kidney issues. Additionally, patients with severe infections, heart failure, liver dysfunction, pregnant or nursing women should not use this medication. While this medication lowers blood glucose levels, there is a risk of hypoglycemia when used with insulin or other hypoglycemic agents, so caution is advised. Regular kidney function tests should be conducted before and during treatment to ensure there are no issues, and the medication should be temporarily stopped in case of dehydration, severe vomiting, or diarrhea. During the use of this medication, urinary tract infections or genital infections may occur, so if symptoms of infection arise, notify a healthcare provider immediately. Furthermore, this medication can decrease fluid volume, which may lead to low blood pressure or dehydration symptoms, hence patients, particularly the elderly or those with cardiovascular conditions, should be cautious. Pregnant women or those who might become pregnant should not take this medication; nursing mothers should discontinue breastfeeding while on this medication to be safe. The risk of lactic acidosis may increase when taken with alcohol, so alcohol consumption should be avoided. Patients scheduled for surgery should stop taking the medication 48 hours prior and resume only after normal kidney function has been restored post-surgery. During the use of this medication, blood sugar levels should be frequently monitored, and immediate action should be taken if symptoms of hypoglycemia appear. Finally, this medication is not recommended for children, and elderly patients may require dose adjustments based on their kidney function.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, hence should be stored in a tightly closed container. It is also important to maintain the medication at temperatures between 1 to 30 degrees Celsius to preserve its effectiveness.
Pinkish-white, double convex, oval film-coated tablet
10 tablets/box [10 tablets/PTP × 1], 60 tablets/box [10 tablets/PTP × 6], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Donghwa Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.